WallStSmart

Tenet Healthcare Corporation (THC)vsViking Holdings Ltd (VIK)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tenet Healthcare Corporation generates 230% more annual revenue ($21.45B vs $6.50B). VIK leads profitability with a 17.6% profit margin vs 7.9%. THC trades at a lower P/E of 10.1x. VIK earns a higher WallStSmart Score of 66/100 (B-).

THC

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 7.3Quality: 6.3
Piotroski: 6/9Altman Z: 1.69

VIK

Strong Buy

66

out of 100

Grade: B-

Growth: 9.3Profit: 8.5Value: 4.7Quality: 4.3
Piotroski: 6/9Altman Z: 0.16
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

THCUndervalued (+78.8%)

Margin of Safety

+78.8%

Fair Value

$1068.55

Current Price

$190.38

$878.17 discount

UndervaluedFair: $1068.55Overvalued

Intrinsic value data unavailable for VIK.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

THC4 strengths · Avg: 9.5/10
P/E RatioValuation
10.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
30.3%10/10

Every $100 of equity generates 30 in profit

EPS GrowthGrowth
87.6%10/10

Earnings expanding 87.6% YoY

Free Cash FlowQuality
$1.46B8/10

Generating 1.5B in free cash flow

VIK4 strengths · Avg: 9.0/10
Return on EquityProfitability
254.5%10/10

Every $100 of equity generates 255 in profit

EPS GrowthGrowth
226.6%10/10

Earnings expanding 226.6% YoY

Operating MarginProfitability
20.9%8/10

Strong operational efficiency at 20.9%

Revenue GrowthGrowth
27.8%8/10

Revenue surging 27.8% year-over-year

Areas to Watch

THC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.8%4/10

2.8% revenue growth

Altman Z-ScoreHealth
1.694/10

Distress zone — elevated risk

Profit MarginProfitability
7.9%3/10

7.9% margin — thin

PEG RatioValuation
4.802/10

Expensive relative to growth rate

VIK3 concerns · Avg: 2.7/10
P/E RatioValuation
32.7x4/10

Premium valuation, high expectations priced in

Price/BookValuation
33.7x2/10

Trading at 33.7x book value

Altman Z-ScoreHealth
0.162/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : THC

The strongest argument for THC centers on P/E Ratio, Return on Equity, EPS Growth.

Bull Case : VIK

The strongest argument for VIK centers on Return on Equity, EPS Growth, Operating Margin. Profitability is solid with margins at 17.6% and operating margin at 20.9%. Revenue growth of 27.8% demonstrates continued momentum.

Bear Case : THC

The primary concerns for THC are Revenue Growth, Altman Z-Score, Profit Margin.

Bear Case : VIK

The primary concerns for VIK are P/E Ratio, Price/Book, Altman Z-Score.

Key Dynamics to Monitor

THC profiles as a value stock while VIK is a growth play — different risk/reward profiles.

VIK carries more volatility with a beta of 1.57 — expect wider price swings.

VIK is growing revenue faster at 27.8% — sustainability is the question.

THC generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

THC scores higher overall (66/100 vs 66/100). Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Tenet Healthcare Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Viking Holdings Ltd

CONSUMER CYCLICAL · TRAVEL SERVICES · USA

Viking Holdings Ltd engages in the passenger shipping and other forms of passenger transport in North America, the United Kingdom, and internationally. The company is headquartered in Pembroke, Bermuda.

Want to dig deeper into these stocks?